New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015

New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017

“…Although probably all of the literature reviews in this series (at least all in the last year had; [ 6 – 9 ]) are having new information on the role of EBV in malignant lymphoma, this one has more than average. Cohen et al [ 10 ] builds on recent data that EBV-mediated B cell transformation is not only achieved through the action of latent proteins, but that also lytic EBV replication has a certain pathogenic role in lymphomagenesis.…”

New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016

“…All in all, the briefest paragraph on prognostic factors in the series of review, you can read the argumentation in the previous issue [ 40 ].…”

New developments in the pathology of malignant lymphoma: a review of the literature published from June–August 2016

“…The presence of a virus even defines some lymphoma types like Epstein-Barr virus (EBV)-positive DLBCL of the elderly. However, Monabati et al [ 9 ] add further evidence that the age criterium is not relevant and that “elderly” needs to be omitted (see also [ 10 , 11 )]. Out of 95 their DLBCL, 11.6 % were EBV positive (7.5 and 14.5 % in the young and old groups).…”